EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update
(2024) In Annals of the Rheumatic Diseases- Abstract
INTRODUCTION: Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for the non-pharmacological core management of hip and knee OA were published in 2013. Given the large number of subsequent studies, an update is needed.
METHODS: The Standardised Operating Procedures for EULAR recommendations were followed. A multidisciplinary Task Force with 25 members representing 14 European countries was established. The Task Force agreed on an updated search strategy of 11 research questions. The systematic literature review encompassed dates from 1... (More)
INTRODUCTION: Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for the non-pharmacological core management of hip and knee OA were published in 2013. Given the large number of subsequent studies, an update is needed.
METHODS: The Standardised Operating Procedures for EULAR recommendations were followed. A multidisciplinary Task Force with 25 members representing 14 European countries was established. The Task Force agreed on an updated search strategy of 11 research questions. The systematic literature review encompassed dates from 1 January 2012 to 27 May 2022. Retrieved evidence was discussed, updated recommendations were formulated, and research and educational agendas were developed.
RESULTS: The revised recommendations include two overarching principles and eight evidence-based recommendations including (1) an individualised, multicomponent management plan; (2) information, education and self-management; (3) exercise with adequate tailoring of dosage and progression; (4) mode of exercise delivery; (5) maintenance of healthy weight and weight loss; (6) footwear, walking aids and assistive devices; (7) work-related advice and (8) behaviour change techniques to improve lifestyle. The mean level of agreement on the recommendations ranged between 9.2 and 9.8 (0-10 scale, 10=total agreement). The research agenda highlighted areas related to these interventions including adherence, uptake and impact on work.
CONCLUSIONS: The 2023 updated recommendations were formulated based on research evidence and expert opinion to guide the optimal management of hip and knee OA.
(Less)
- author
- organization
- publishing date
- 2024-01-11
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of the Rheumatic Diseases
- article number
- 224997
- publisher
- BMJ Publishing Group
- external identifiers
-
- scopus:85183295213
- pmid:38212040
- ISSN
- 1468-2060
- DOI
- 10.1136/ard-2023-225041
- language
- English
- LU publication?
- yes
- additional info
- © European Alliance of Associations for Rheumatology, EULAR 2024. Re-use permitted under CC BY-NC-ND. No commercial re-use. No derivatives. See rights and permissions. Published by BMJ on behalf of EULAR.
- id
- c5578d71-ecaf-4111-888b-e1f3c68d29b0
- date added to LUP
- 2024-01-31 03:26:58
- date last changed
- 2024-04-22 22:08:48
@article{c5578d71-ecaf-4111-888b-e1f3c68d29b0, abstract = {{<p>INTRODUCTION: Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for the non-pharmacological core management of hip and knee OA were published in 2013. Given the large number of subsequent studies, an update is needed.</p><p>METHODS: The Standardised Operating Procedures for EULAR recommendations were followed. A multidisciplinary Task Force with 25 members representing 14 European countries was established. The Task Force agreed on an updated search strategy of 11 research questions. The systematic literature review encompassed dates from 1 January 2012 to 27 May 2022. Retrieved evidence was discussed, updated recommendations were formulated, and research and educational agendas were developed.</p><p>RESULTS: The revised recommendations include two overarching principles and eight evidence-based recommendations including (1) an individualised, multicomponent management plan; (2) information, education and self-management; (3) exercise with adequate tailoring of dosage and progression; (4) mode of exercise delivery; (5) maintenance of healthy weight and weight loss; (6) footwear, walking aids and assistive devices; (7) work-related advice and (8) behaviour change techniques to improve lifestyle. The mean level of agreement on the recommendations ranged between 9.2 and 9.8 (0-10 scale, 10=total agreement). The research agenda highlighted areas related to these interventions including adherence, uptake and impact on work.</p><p>CONCLUSIONS: The 2023 updated recommendations were formulated based on research evidence and expert opinion to guide the optimal management of hip and knee OA.</p>}}, author = {{Moseng, Tuva and Vliet Vlieland, Theodora P M and Battista, Simone and Beckwée, David and Boyadzhieva, Vladimira and Conaghan, Philip G and Costa, Daniela and Doherty, Michael and Finney, Andrew G and Georgiev, Tsvetoslav and Gobbo, Milena and Kennedy, Norelee and Kjeken, Ingvild and Kroon, Féline P B and Lohmander, L Stefan and Lund, Hans and Mallen, Christian D and Pavelka, Karel and Pitsillidou, Irene A and Rayman, Margaret P and Tveter, Anne Therese and Vriezekolk, Johanna E and Wiek, Dieter and Zanoli, Gustavo and Østerås, Nina}}, issn = {{1468-2060}}, language = {{eng}}, month = {{01}}, publisher = {{BMJ Publishing Group}}, series = {{Annals of the Rheumatic Diseases}}, title = {{EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update}}, url = {{http://dx.doi.org/10.1136/ard-2023-225041}}, doi = {{10.1136/ard-2023-225041}}, year = {{2024}}, }